肝脏 ›› 2024, Vol. 29 ›› Issue (3): 278-284.

• 病毒性肝炎 • 上一篇    下一篇

基于血清抗-HBc定量建立慢性HBV感染者显著肝组织病理学改变的无创诊断模型

林维佳, 陆伟, 王雁冰, 张占卿   

  1. 201508 上海市公共卫生临床中心肝胆内科
  • 收稿日期:2023-12-13 出版日期:2024-03-31 发布日期:2024-05-16
  • 通讯作者: 张占卿,Email: doctorzzq@shaphc.org
  • 基金资助:
    上海市公共卫生临床中心院级科研课题资助项目(KY-GW-2023-28)

Based on serum anti-HBC quantification to establish a noninvasive diagnostic model of significant liver histopathological changes in chronic HBV infection

LIN Wei-jia, LU Wei, WANG Yan-bing, ZHANG Zhan-qing   

  1. Department of Hepatobiliary, Shanghai Public Health Clinical Center, Shanghai 201508, China
  • Received:2023-12-13 Online:2024-03-31 Published:2024-05-16
  • Contact: ZHANG Zhan-qing,Email: doctorzzq@shaphc.org

摘要: 目的 建立慢性HBV感染者显著肝组织病理学改变的诊断模型,并评估模型的诊断价值。方法 选取2011年12月—2017年12月在上海市公共卫生临床中心肝胆内科住院并进行肝活检且未经抗病毒治疗的457例慢性HBV感染者,收集患者的肝活检病理结果及常规实验室指标,并进行抗-HBc定量检测。依据Scheuer方法进行炎症分级(G)及纤维化分期(S),分为显著与非显著肝坏死性炎症、肝纤维化和肝损伤组。根据单因素分析和多因素logistic回归分析构建预测显著肝坏死性炎症、显著肝纤维化和显著肝损伤的数学模型,并与FIB-4、GPR、APRI、RPR利用ROC曲线分析评估模型的预测性能,根据ROC曲线下面积(AUC)比较诊断价值。结果 457例患者中显著肝坏死性炎症(G≥2)178例,非显著肝坏死性炎症(G<2)279例,显著肝纤维化(S≥2)248例,非显著肝纤维化(S<2)209例,显著肝损伤(G≥2或/和S≥2)264例,非显著肝坏死性炎症(G<2和S<2)193例。根据单因素分析和多因素logistic回归分析结果,分别建立由抗-HBc、AST、PLT、TTR等指标组成的预测显著肝坏死性炎症的数学模型M-SHN,由抗-HBc、PLT、ChE、TTR、性别等指标组成的预测显著肝纤维化的数学模型M-SHF,及由抗-HBc、PLT、TTR、性别等指标组成的预测显著肝损伤的数学模型M-SHI,并通过ROC曲线分析各模型的预测价值,M-SHN模型的AUC为0.826(95%CI: 0.788~0.860),M-SHF模型的AUC为0.776(95%CI: 0.735~0.814),M-SHI模型的AUC为0.789(95%CI: 0.748~0.825)。结论 基于患者常规实验室指标及血清抗-HBc定量,建立了M-SHN、M-SHF、M-SHI模型,对于显著肝坏死性炎症、显著肝纤维化、显著肝损伤有较为可靠的预测价值,可帮助临床评估患者是否需要进行抗病毒治疗。

关键词: 慢性HBV感染, 抗-HBc定量, 炎症, 纤维化, 诊断

Abstract: Objective To establish a mathematical model for predicting significant liver histopathological changes in chronic HBV infection, and evaluate the diagnostic value of the model. Methods A retrospective analysis was performed on 457 patients with chronic HBV infection who were hospitalized and underwent liver biopsy without antiviral therapy in the Department of Hepatobiliary Medicine of Shanghai Public Health Clinical Center from December 2011 to December 2017. The pathological results of liver biopsy and routine laboratory indexes were collected, and anti-HBc quantitative detection was performed. According to Scheuer method, the inflammatory grade (G) and fibrosis stage (S) were divided into significant and non-significant hepatic necrotizing inflammation, hepatic fibrosis and hepatic injury groups. A mathematical model for predicting significant liver necrotizing inflammation, significant liver fibrosis and significant liver injury was constructed based on univariate analysis and multivariate Logistic regression analysis.Compared with FIB-4, GPR, APRI and RPR, the predictive performance of the model was evaluated by ROC curve analysis, and the diagnostic value was compared according to the area under ROC curve (AUC). Results Of the 457 patients, 178 had significant hepatic necrotizing inflammation (G≥2) and 279 had non-significant hepatic necrotizing inflammation (G<2), 248 had significant liver fibrosis (S≥2) and 209 had non-significant liver fibrosis (S<2), 264 had significant liver injury (G≥2 or/and S≥2) and 193 had non-significant liver necrotizing inflammation (G< 2 and S<2). According to the results of univariate analysis and multivariate Logistic regression analysis, the mathematical model M-SHN composed of anti-HBc, AST, PLT and TTR was established to predict significant liver necrotizing inflammation, and the mathematical model M-SHF composed of anti-HBc, PLT, ChE, TTR and gender to predict significant liver fibrosis, and M-SHI, a mathematical model composed of anti-HBc, PLT, TTR and sex, predicted significant liver injury, respectively. The predictive value of each model was analyzed by ROC curve. The AUC of M-SHN was 0.826 (95%CI: 0.788~0.860), and M-SHF was 0.776 (95%CI: 0.735~0.814), and M-SHI was 0.789 (95%CI: 0.748~0.825). Conclusion Based on routine laboratory indicators and serum anti-HBC quantification, M-SHN, M-SHF and M-SHI models were established, which have reliable predictive value for significant liver necrotizing inflammation, significant liver fibrosis and significant liver injury, and can help clinical evaluation of whether patients need antiviral therapy.

Key words: Chronic HBV infection, Anti-HBc quantification, Inflammation, Fibrosis, Diagnosis